A Mass Balance Study of Oral [14C] ABBV-932 in Healthy Adult Male Participants
NCT06953934 · Status: NOT_YET_RECRUITING · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 8
Last updated 2025-08-08
Summary
The main objective of this study is to assess the safety and tolerability of ABBV-932 in healthy adult male participants.
Conditions
- Healthy Volunteer
Interventions
- DRUG
-
ABBV-932
Oral Capsule
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
ABBVIE INC. · AbbVie
Study Design
- Allocation
- NA
- Purpose
- BASIC_SCIENCE
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- MALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2025-10-14
- Primary Completion
- 2026-02-28
- Completion
- 2026-02-28
More Related Trials
-
A Study to Evaluate Adverse Events, How the Drug is Tolerated, and How the Drug Moves Through the Body of Intravenous Infusions of ABBV-8736 in Adult Healthy Volunteers
NCT07141199 ·Status: COMPLETED ·Phase: PHASE1
-
Metabolism and Pharmacokinetics of [14C]-BIBR 953 ZW After Administration of Single Doses of [14C]-BIBR 953 ZW Intravenously or [14C]-BIBR 1048 Oral Solution in Healthy Male Volunteers
NCT02171442 ·Status: COMPLETED ·Phase: PHASE1
-
An Investigational Study to Evaluate Experimental Medication BMS-986165 Given as a Tablet and Solution in Healthy Male Participants
NCT03739788 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Assess Adverse Events and Compare How Crushed, Ground, and Intact Oral Tablets Venetoclax Moves Through the Body of Healthy Female Adult Volunteers
NCT05909553 ·Status: COMPLETED ·Phase: PHASE1
-
Mass Balance and Absolute Bioavailability Study of RO7049389 in Healthy Volunteers
NCT04729309 ·Status: COMPLETED ·Phase: PHASE1
-
A Study in Healthy Men to Test How BI 685509 is Processed in the Body
NCT05515328 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Assess Relative Bioavailability of BMS-986435 Formulations in Healthy Adult Participants
NCT06577259 ·Status: COMPLETED ·Phase: PHASE1
-
Tolerability and Pharmacokinetics/-Dynamics of BIBT 986 BS in Healthy Male Subjects
NCT02254083 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate the Bioavailability of BMS-986205
NCT03374228 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of CC-97489 in Healthy Adult Participants
NCT05099822 ·Status: TERMINATED ·Phase: PHASE1
-
A Study to Assess How the Drug Moves Through the Body, Adverse Events, and Tolerability of Oral ABBV-722 Capsules of Single and Multiple Ascending Doses in Adult Participants and Single Doses in Adult Asian Participants
NCT06673238 ·Status: RECRUITING ·Phase: PHASE1
-
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Multiple, Rising Oral Doses of BI 11634 Oral Solution in Healthy Male Volunteers
NCT02214940 ·Status: COMPLETED ·Phase: PHASE1
-
Evaluate the Bioavailability Between 2 BMS-986141 Formulations in Healthy Participants
NCT03035734 ·Status: WITHDRAWN ·Phase: PHASE1
-
Investigation of Single Rising Doses of BI 685509
NCT02694354 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Evaluate the Pharmacokinetic Comparability of CC-93538 From Two Different Drug Concentrations in Healthy Adult Subjects
NCT04373187 ·Status: COMPLETED ·Phase: PHASE1
-
A Study in Healthy Men to Test How BI 1291583 is Taken up by the Body
NCT06166992 ·Status: COMPLETED ·Phase: PHASE1
-
Safety, Tolerability, and Pharmacokinetics of Single Rising Oral Doses of BIRB 1017 BS as a Solution in PEG 400 / 26% Ethanol Administered to Healthy Male Subjects
NCT02184338 ·Status: COMPLETED ·Phase: PHASE1
-
A Bioavailability and Pharmacokinetic Study of Subcutaneous and Intravenous RO6811135 in Healthy Volunteers
NCT01802853 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Tolerability of BI 638683 After Single Rising Oral Doses in Healthy Male Subjects
NCT01195688 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Assess Adverse Events and How Oral ABBV-990 Moves Through the Body of Adult Healthy Participants
NCT05475821 ·Status: TERMINATED ·Phase: PHASE1
-
A Trial to Assess the Absorption, Metabolism, Excretion, and Mass Balance of [14C]-Darigabat After a Single Oral Dose in Healthy Male Participants
NCT06435923 ·Status: COMPLETED ·Phase: PHASE1
-
Tolerability and Pharmacokinetics/-Dynamics of Single Rising Doses BIBT 986 BS in Healthy Male Subjects
NCT02254057 ·Status: COMPLETED ·Phase: PHASE1
-
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single Rising Oral Doses and Multiple Rising Oral Doses of BI 1356 BS in Healthy Male Volunteers
NCT02183311 ·Status: COMPLETED ·Phase: PHASE1
-
Safety, Pharmacokinetics, and Pharmacodynamics of BIRT 2584 XX in Healthy Male Volunteers
NCT02259894 ·Status: COMPLETED ·Phase: PHASE1
-
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Rising Oral Doses of BI 639667
NCT02133482 ·Status: WITHDRAWN ·Phase: PHASE1